94508 ⎘
Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms; Two or more oxygen, sulphur or nitrogen atoms; Three or more oxygen or sulfur atoms Barbituric acids
ELECTROLYTE SOLUTION FOR RECHARGEABLE LITHIUM BATTERY AND RECHARGEABLE LITHIUM BATTERY INCLUDING THE SAME
#2POLYMERIZABLE COMPOSITIONS INCLUDING A POLYMERIZABLE COMPONENT AND A REDOX INITIATION SYSTEM CONTAINING A PHOTOLABILE REDUCING AGENT, AND A PHOTOLABILE REDUCING AGENT
#3CARBON MONOXIDE PRODRUGS FOR THE TREATMENT OF MEDICAL DISORDERS
#4SOLID STATE FORMS OF DAPRODUSTAT AND PROCESS FOR THEIR PREPARATION
#5COMPOUND, POLYMERIZABLE COMPOSITION, OPTICALLY ANISOTROPIC FILM, OPTICAL FILM, POLARIZING PLATE, AND IMAGE DISPLAY DEVICE
#6NOVEL MANUFACTURING METHOD OF DAPRODUSTAT AND PRECURSORS THEREOF
#7COMPOUNDS AND METHODS TO TARGET GLUCOSE-STIMULATED PHOSPHOHISTIDINE SIGNALING AND ESOPHAGEAL CANCER GROWTH
#8CRYSTALLINE FORMS OF GSK1278863, PREPARATION METHOD AND PHARMACEUTICAL USE THEREOF
#9Prolyl Hydroxylase Inhibitors
#10Barbituric acid derivatives, their preparation and use thereof as leukocyte transmigration inhibitors and for treating inflammatory diseases, autoimmune diseases and cancer
#11PYRIMIDINE COMPOUND AND MEDICAL USE THEREOF
#12CRYSTAL FORM OF DAPRODUSTAT, PREPARATION METHOD THEREFOR AND USE THEREOF
#13Polycyclic compound
#14Prolyl hydroxylase inhibitors
#15Carbon monoxide prodrugs for the treatment of medical disorders
#16Crystalline forms of GSK1278863, preparation method and pharmaceutical use thereof
#17SELECTIVE CALCIUM CHANNEL ANTAGONISTS
#18Photolabile barbiturate compounds
#19Anticancer 1,3-dioxane-4,6-dione derivatives and method of combinatorial synthesis thereof
#20Electrolyte and electrochemical device
#21Crystalline forms of GSK1278863, preparation method and pharmaceutical use thereof
#22Inhibition of glutaminase C
#23Barbituric acid derivatives, their preparation and use thereof as leukocyte transmigration inhibitors and for treating inflammatory diseases, autoimmune diseases and cancer
#24Prolyl Hydroxylase Inhibitors
#25PYRIMIDINE COMPOUND AND MEDICAL USE THEREOF
#26Barbituric acid derivatives comprising cationic and lipophilic groups
#27Compounds useful as modulators of TRPM8
#28SELECTIVE CALCIUM CHANNEL ANTAGONISTS
#29O-substituted hydroxamic acids
#30NEGATIVE PHOTOCHROMIC MATERIALS WITH TUNABLE PROPERTIES
#31Prolyl hydroxylase inhibitors
#32PYRIMIDINE COMPOUND AND MEDICAL USE THEREOF
#33N-substituted hydroxamic acids with carbon-based leaving groups as efficient HNO donors and uses thereof
#34Oligomer and lithium battery
#35Bifunctional compounds and use for reducing uric acid levels
#36Compounds useful as modulators of TRPM8
#37LITHIUM SECONDARY BATTERY
#38Meldrum's acid, barbituric acid and pyrazolone derivatives substituted with hydroxylamine as HNO donors
#39PYRIMIDINE COMPOUND AND MEDICAL USE THEREOF
#40Selective calcium channel antagonists
#41Prolyl hydroxylase inhibitors
#42N-substituted hydroxylamine derivatives with carbon-based leaving groups
#43Compound having skin-whitening, anti-oxidizing and PPAR activities and medical use thereof
#44N-hydroxylamino-barbituric acid derivatives
#45Compounds useful as modulators of TRPM8
#46Preparation process of carboxylic acid derivatives and intermediates thereof
#47C-Rel inhibitors and uses thereof
#48Pyrimidine-2,4,6-triones for use in the treatment of amyotrophic lateral sclerosis
#49OPTICAL FILM, POLARIZING PLATE AND LIQUID CRYSTAL DISPLAY USING THE SAME, AND COMPOUND
#50Shikimate pathway inhibitors and the use thereof
#51Meldrum's acid, barbituric acid and pyrazolone derivatives substituted with hydroxylamine as HNO donors
#52Quinoxaline compounds and derivatives
#53Charge control agent and toner using the same
#54Quinoxaline compounds and derivatives
#55Inhibition of glutaminase C
#56Selective calcium channel antagonists
#57PYRIMIDINE-2,4,6-TRIONES FOR USE IN THE TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS
#58Process for the preparation of alogliptin
#59Photoelectric conversion material, film containing the material, photoelectric conversion device, production method thereof, photosensor, imaging device and their use methods
#60NOVEL ANTAGONISTS OF THE HUMAN FATTY ACID SYNTHASE THIOESTERASE
#61Pyrimidine compound and medical use thereof
#62Prolyl hydroxylase inhibitors
#63Tetrahalogenated compounds useful as inhibitors of angiogenesis
#64Phenobarbital derivatives useful in immunoassay
#65PYRIMIDINE COMPOUND AND MEDICAL USE THEREOF
#66BARBITURIC ACID ANALOGS AS THERAPEUTIC AGENTS
#675-(1,1'Biphenyl)-4-Yl-5-(4-(4-Aminoacylphenyl)-Piperazin)-1-Yl-Pyrimidine-2,4,6,-Trione Derivatives, As Inhibitors Of Zinc Metallondopeptidases, Their Preparation And Use
#68NOVEL ANTAGONISTS OF THE HUMAN FATTY ACID SYNTHASE THIOESTERASE
#69Process for preparing 1-methoxymethyl 5,5-diphenybarbituric acid
#70Barbituric acid derivatives as inhibitors of TNF-α converting enzyme (TACE) and/or matrix metalloproteinases
#71Detection of transmembrane potentials by optical methods
#72Process for preparing 1-methoxymethyl-5,5-diphenylbarbituric acid
#73O-coordinated metal chelates and their use in optical recording media having high storage capacity
#74Pyrimidine compound and medical use thereof
#75Process for preparing 1-methoxymethyl-5,5-diphenylbarbituric acid
#76Pyrimidine-2,4,6-trione metalloproteinase inhibitors
#77Method for the synthesis of amides and related products from esters or ester-like compounds
#78Barbituric acid derivatives, their preparation and use thereof as leukocyte transmigration inhibitors and for treating inflammatory diseases, autoimmune diseases and cancer